PAREXEL International Corp. Director Patrick Fortune Sells 7,000 Shares (PRXL)
PAREXEL International Corp. (NASDAQ:PRXL) Director Patrick Fortune sold 7,000 shares of PAREXEL International Corp. stock on the open market in a transaction dated Wednesday, September 11th. The shares were sold at an average price of $48.31, for a total value of $338,170.00. Following the completion of the transaction, the director now directly owns 22,182 shares in the company. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on PRXL. Analysts at Zacks downgraded shares of PAREXEL International Corp. (NASDAQ:PRXL) from an “outperform” rating to a “neutral” rating in a research note to investors on Monday. They now have a $55.00 price target on the stock. Separately, analysts at Sterne Agee downgraded shares of PAREXEL International Corp. (NASDAQ:PRXL) from a “neutral” rating to an “underperform” rating in a research note to investors on Wednesday, August 14th. They now have a $36.00 price target on the stock, down previously from $44.00. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of PAREXEL International Corp. (NASDAQ:PRXL) in a research note to investors on Thursday, August 8th. They now have a $47.00 price target on the stock, up previously from $46.00.
One investment analyst has rated the stock with a sell rating, five have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. PAREXEL International Corp. has a consensus rating of “Hold” and a consensus target price of $43.71.
Shares of PAREXEL International Corp. (NASDAQ:PRXL) traded up 1.01% on Friday, hitting $49.08. The stock had a trading volume of 177,314 shares. PAREXEL International Corp. has a one year low of $28.45 and a one year high of $53.55. The stock’s 50-day moving average is $48.72 and its 200-day moving average is $44.58. The company has a market cap of $2.759 billion and a P/E ratio of 30.18.
PAREXEL International Corp. (NASDAQ:PRXL) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the analysts’ consensus estimate of $0.43 by $0.07. The company had revenue of $463.10 million for the quarter, compared to the consensus estimate of $455.23 million. During the same quarter in the prior year, the company posted $0.34 earnings per share. The company’s quarterly revenue was up 1.2% on a year-over-year basis. Analysts expect that PAREXEL International Corp. will post $2.03 EPS for the current fiscal year.
PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.